← Search organizationsRegulatory Engagement Tracker
← OpenPolisSign in

National Consumers League

Unclaimed
Industry
nonprofit organization management
Staff
44
HQ
1701 K Street, NW, Suite 1200, Washington, DC 20006, US
Phone
+1 202-835-3323
Website
www.nclnet.org

Engagement overview

National Consumers League has filed 47 public comments across 44 dockets at 9 federal agencies, most actively at the Food and Drug Administration.

47
Comments filed
44
Dockets engaged
9
Agencies
Jul 24, 2026
Last filing

Is this your organization?

Claim National Consumers League to unlock owner-only intelligence across your 44 dockets:

  • Coalition map — every organization that files alongside you
  • Ally & opposition tags on your co-filers
  • AI briefs on the rulemakings you engage
  • Deadline calendar & alerts for open comment windows
Claim this profile →or book a meetingFree · verify instantly with your work email.

Agency footprint

All agenciesFDA30CDC4FTC3CPSC2CFPB1DOT1EPA1FAA1NHTSA1

Dockets · FDA (30)

sorted by most recent filing
FDANonrulemakingFDA-2018-N-3240

List of Bulk Drug Substances For Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Notice

1 of your filingslast filed Jul 24, 202628 co-filers
FDANonrulemakingFDA-2025-P-4153

Requests that the FDA require revisions to the labeling for all over-the-counter acetaminophen-containing drug products marketed under the Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use monograph (OTC Monograph M013): (i) a revision to the “Warnings” subsection, currently found at M013.50(c)(1)(iii) in the Labeling section.

1 of your filingslast filed Nov 6, 202517 co-filers
FDANonrulemakingFDA-2024-N-3609

Development of an Enhanced Systematic Process for FDA’s Post-Market Assessment of Chemicals in Food; Public Meeting; Request for Comments

1 of your filingslast filed Feb 20, 202532 co-filers
FDARulemakingFDA-2019-N-5959

Medication Guides: Patient Medication Information; Proposed Rule

1 of your filingslast filed Jan 26, 202423 co-filers
FDARulemakingFDA-2016-D-2335

Use of the Term “Healthy” in the Labeling of Human Food Products

1 of your filingslast filed Feb 14, 2023137 co-filers
FDANonrulemakingFDA-2021-N-1349

Tobacco Product Standard for Menthol in Cigarettes

1 of your filingslast filed Aug 3, 2022345 co-filers
FDANonrulemakingFDA-2022-N-0165

Providing Mail-Back Envelopes and Education on Safe Disposal With Opioid Analgesics Dispensed in an Outpatient Setting; Establishment of a Public Docket; Request for Comments

1 of your filingslast filed Jun 22, 202223 co-filers
FDANonrulemakingFDA-2021-N-0555

Medical Devices; Ear, Nose, and Throat Devices; Establishing Over-the-Counter Hearing Aids and Aligning Other Regulations

2 of your filingslast filed Dec 22, 202161 co-filers
FDARulemakingFDA-1978-N-0018

Sunscreen Drug Products -OPEN

1 of your filingslast filed Nov 15, 202146 co-filers
FDANonrulemakingFDA-2010-N-0128

Prescription Drug User Fee Act

1 of your filingslast filed Aug 21, 202046 co-filers
FDARulemakingFDA-2011-F-0171

Food Labeling; Calorie Labeling of Articles of Food in Vending Machines

1 of your filingslast filed Sep 10, 201825 co-filers
FDANonrulemakingFDA-2017-N-3615

Administering the Hatch-Waxman Amendments: Ensuring an Appropriate Balance Between Innovation and Access

1 of your filingslast filed Sep 19, 201724 co-filers
FDANonrulemakingFDA-2015-N-3326

Biosimilar User Fee Act

1 of your filingslast filed Oct 26, 201613 co-filers
FDANonrulemakingFDA-2016-D-2268

Insanitary Conditions at Compounding Facilities

2 of your filingslast filed Oct 17, 201621 co-filers
FDANonrulemakingFDA-2016-D-1309

Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry; Availability

2 of your filingslast filed Oct 12, 201610 co-filers
FDANonrulemakingFDA-2003-N-0313

Toll-Free Number for Reporting Adverse Events on Labeling for Human Drug Products

1 of your filingslast filed Feb 9, 20166 co-filers
FDARulemakingFDA-2009-P-0147

To Amend the Standard of Identity for Milk, 21 C.F.R. 131.110, to Includes Optional Characterizing Flavoring Ingredients With any Safe and Suitable Sweetener

1 of your filingslast filed Nov 25, 201511 co-filers
FDARulemakingFDA-2007-N-0363

Electronic Distribution of Prescribing Information for Prescription Drug Products; Public Hearing

1 of your filingslast filed May 20, 201523 co-filers
FDARulemakingFDA-2013-N-0500

Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products

1 of your filingslast filed Mar 27, 201531 co-filers
FDANonrulemakingFDA-1991-N-0365

Legal Status of Approved Labeling for Prescription Drugs - CLOSED

1 of your filingslast filed Feb 11, 201564 co-filers
FDARulemakingFDA-2014-N-0189

Deeming Tobacco Products To Be Subject to the Food, Drug, and Cosmetic Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Regulations on the Sale and Distribution of Tobacco Products and Required Warning Statements for Tobacco Products

1 of your filingslast filed Sep 4, 20148 co-filers
FDARulemakingFDA-2011-N-0143

Foreign Supplier Verification Program

1 of your filingslast filed Apr 29, 2014102 co-filers
FDANonrulemakingFDA-2012-N-1154

Framework for Pharmacy Compounding: State and Federal Roles

1 of your filingslast filed Jan 24, 201319 co-filers
FDANonrulemakingFDA-2011-D-0889

Guidance for Industry on Revising Approved Conditions of Use for New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals to Align with GFI #209; Availability

1 of your filingslast filed Jul 18, 201253 co-filers
FDARulemakingFDA-2008-N-0326

New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition

1 of your filingslast filed Mar 6, 201272 co-filers
FDANonrulemakingFDA-2011-N-0400

Approaches to Reducing Sodium Consumption

1 of your filingslast filed Dec 12, 201146 co-filers
FDANonrulemakingFDA-2011-N-0556

Center for Devices and Radiological Health 510(k) Clearance Process; Institute of Medicine Report: “Medical Devices and the Public’s Health, The FDA 510(k) Clearance Process at 35 Years;” Request for Comments

1 of your filingslast filed Oct 7, 201124 co-filers
FDARulemakingFDA-2011-F-0172

Nutrition Labeling of Standard Menu Items in Restaurants and Similar Retail Food Establishments

1 of your filingslast filed Jul 7, 201180 co-filers
FDANonrulemakingFDA-2010-N-0437

Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing

1 of your filingslast filed Oct 21, 20107 co-filers
FDANonrulemakingFDA-2007-N-0214

Prescription Drug User Fee Act (PDUFA): Public Meeting

1 of your filingslast filed Jan 9, 200913 co-filers

Attribution is name-based and imperfect. Firmographic data is third-party sourced and shown for demonstration. regulations.gov data is public record.